MENU
IMUC
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

EOM Pharmaceutical Holdings (IMUC) Ownership - Who owns EOM Pharmaceutical Holdings?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
136 Summit Avenue
Phone
+1 201 351-0605
Employees
4
Web
https://www.eompharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.13M
P/E Ratio
0.02
Total Cash
85.29K
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
0.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IMUC
Capitalization
19.1M
P/E Ratio
0.02
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
85.3K
Total Cash/Share
0.00
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
3.43M
P/B Ratio
0.35
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4.19K
Current Ratio
9.53
Current Revenue Per Employee
150000.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
113M
Total Liabilities
2.36M
Total Volume MTD
N/A
Value
1
Gain YTD
-27.198
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of immune based therapies for the treatment of brain and other cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
136 Summit Avenue
Phone
+1 201 351-0605
Employees
4
Web
https://www.eompharma.com